title: [Preclinical in vitro and in vivo models for the assessment of biological activity in biosimilarity studies].
abstract: A drug that contains a recombinant protein as an active principle is called a biotechnological drug or biopharmaceutical.There are currently over 300 biopharmaceuticals worldwide. Many of these contains a similar active principle (biosimilar drug) as other previously registered (innovator drug). It has suggested that due to the complex implications in a formulation containing a protein, the manufacturing process is a key factor for efficacy and safety requirements. In fact, certain variability has been detected of the protein properties in different lots (or batches) of the same manufacturer, which produce changes at a clinical level. For this reason, the evaluation of biosimilar drugs has acquired great relevance, being the preclinical level of one of the more important stages of the development due to its lower cost (with respect to the clinical level) and its high capacity to detect formulation-manufacture problems. However, the demonstration of comparability at physicochemical, preclinical, and clinical levels is required in order to achieve market registration. In this review the in vitro and in vivo models used for the assessment of proposed biosimilars will be discussed.
authors.affiliation: Instituto Potosino de Investigación Científica y Tecnológica A.C. (IPICyT), San Luís Potosí, S.L.P., México.
authors.forename: Abraham
authors.initials: A
authors.lastname: Escobedo-Moratilla
authors.affiliation: Instituto Potosino de Investigación Científica y Tecnológica A.C. (IPICyT), San Luís Potosí, S.L.P., México.
authors.forename: Ana Paulina
authors.initials: AP
authors.lastname: Barba de la Rosa
authors.affiliation: Dixpertia S.A. de C.V, San Luís Potosí, S.L.P., México.
authors.forename: José Trinidad
authors.initials: JT
authors.lastname: Pérez-Urizar
mesh_terms: D000818:Animals; D059451:Biosimilar Pharmaceuticals / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D066298:In Vitro Techniques; D008954:Models, Biological
chemical_list: D059451:Biosimilar Pharmaceuticals